These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21427199)

  • 1. Do patients screened for hepatocellular carcinoma die significantly older?
    Braillon A
    Gut; 2011 Jul; 60(7):1024. PubMed ID: 21427199
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival.
    Lee SH; Choi HC; Jeong SH; Lee KH; Chung JI; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Choi HC; Yoon CJ; Kang SG
    J Am Geriatr Soc; 2011 Feb; 59(2):241-50. PubMed ID: 21275934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of hepatocellular carcinoma: challenges and opportunities.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1336-8. PubMed ID: 20659219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of hepatocellular carcinoma].
    Cherblanc V; Guiu B
    Rev Prat; 2013 Feb; 63(2):226-8. PubMed ID: 23513791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-epidemiologic and laboratory studies of patients with primary hepatocellular carcinoma].
    Ivan A; Dăneţ D; Iancu L; Tiron S; Ungureanu A; Zavate O
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):735-40. PubMed ID: 2561525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Towards early screening and treatment of hepatocellular carcinoma cirrhosis?].
    Roudot-Thoraval F; Dhumeaux D
    Gastroenterol Clin Biol; 2002; 26(6-7):559-60. PubMed ID: 12193853
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular signature of early hepatocellular carcinoma.
    Suriawinata A; Thung SN
    Oncology; 2010 Jul; 78 Suppl 1():36-9. PubMed ID: 20616582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular classification of hepatocellular carcinoma.
    Llovet JM
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S13-6. PubMed ID: 17969094
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatocellular carcinoma and other liver tumors. The Danish Society of Hepatology (DASL)].
    Grønbaek H;
    Ugeskr Laeger; 2006 Mar; 168(12):1219. PubMed ID: 16571310
    [No Abstract]   [Full Text] [Related]  

  • 11. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hepatocellular carcinoma: being old is not all bad.
    Di Bisceglie AM
    Am J Gastroenterol; 2004 Aug; 99(8):1477-8. PubMed ID: 15307863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatocellular carcinoma in chronic liver disease.
    Kansagara D; Papak J; Jou JH
    Ann Intern Med; 2015 Feb; 162(3):240. PubMed ID: 25643314
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for hepatocellular carcinoma in chronic liver disease.
    Giannini EG; Trevisani F
    Ann Intern Med; 2015 Feb; 162(3):239-40. PubMed ID: 25643313
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for hepatocellular carcinoma in chronic liver disease.
    Chirovsky D; Lich KH; Barritt AS
    Ann Intern Med; 2015 Feb; 162(3):238-9. PubMed ID: 25643312
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M
    Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma--an increasing problem in the Western world].
    Wiedermann KH
    MMW Fortschr Med; 2009 Apr; 151(15):40-3. PubMed ID: 19728682
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening for hepatocellular carcinoma?].
    Ott P; Grønbaek H; Havelund T; Wettergren A; Clemmesen O; Clausen MR; Hansen EF
    Ugeskr Laeger; 2009 Mar; 171(13):1083. PubMed ID: 19321078
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease.
    Taylor-Robinson SD; Wong J; Crossey MM; Khan SA
    Evid Based Med; 2015 Apr; 20(2):59. PubMed ID: 25694341
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for hepatocellular carcinoma.
    Haydon GH; Hayes PC
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.